Week 7: Renal and Lipids

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/80

encourage image

There's no tags or description

Looks like no tags are added yet.

81 Terms

1
New cards

What is the indication for alpha-1 antagonists?

Hypertension (HTN).

2
New cards

What is an example of an alpha-1 antagonist?

Doxazosin.

3
New cards

What are the indications for central alpha-2 agonists?

Hypertension (HTN).

4
New cards

What are three examples of central alpha-2 agonists?

Methyldopa, clonidine, guanfacine.

5
New cards

What is the important prescribing caution for clonidine?

Do not stop or taper abruptly; the photo emphasizes not stopping suddenly.

6
New cards

What are the indications for RAA drugs?

Hypertension, CHF, MI (direct renin inhibitors are marked HTN only).

7
New cards

What suffix identifies ACE inhibitors and what is an example?

-pril; lisinopril.

8
New cards

What suffix identifies ARBs and what is an example?

-sartan; losartan.

9
New cards

What direct renin inhibitor is listed and what is its indication?

Aliskiren; hypertension only.

10
New cards

What are the indications for beta-blockers?

Hypertension, angina, CHF.

11
New cards

What do cardioselective beta-blockers block and which examples are listed?

Beta-1; metoprolol, atenolol, nebivolol.

12
New cards

What do nonselective beta-blockers block and which examples are listed?

Beta-1 and beta-2; propranolol, sotalol.

13
New cards

What receptors do dual-action beta-blockers block and which examples are listed?

Beta-1, beta-2, and alpha-1; carvedilol, labetalol.

14
New cards

Which beta-blocker is handwritten as being used in pregnant adults?

Labetalol.

15
New cards

What are the indications for calcium channel blockers (CCBs)?

Hypertension and angina.

16
New cards

What are examples of non-dihydropyridine CCBs?

Diltiazem and verapamil.

17
New cards

What is the listed dihydropyridine CCB?

Amlodipine.

18
New cards

What are the indications for diuretics on the map?

CHF and hypertension.

19
New cards

What thiazide diuretics are listed?

Hydrochlorothiazide (HCTZ) and chlorthalidone.

20
New cards

What loop diuretic is listed?

Furosemide.

21
New cards

What potassium-sparing aldosterone antagonists (MRAs) are listed?

Spironolactone and eplerenone.

22
New cards

What is the indication for nitrates?

Angina.

23
New cards

What nitrate preparations are listed on the medication map?

Isosorbide mononitrate (IR, SR), isosorbide dinitrate (SL, IR, SR), nitroglycerin (SL, spray, SR, patch, ointment).

24
New cards

What does venous dilation from nitrates do?

Decreases venous return to the heart, reducing preload.

25
New cards

What does arterial dilation from nitrates do?

Decreases afterload.

26
New cards

What adverse effects are associated with nitrates?

Headache, flushing, orthostatic hypotension, reflex tachycardia, and dermatitis with patches.

27
New cards

What drug interactions are listed for nitrates?

Other antihypertensives and PDE-5 inhibitors.

28
New cards

What should patients taking nitrates monitor and how should they change positions?

Monitor blood pressure and pulse; change positions slowly.

29
New cards

What should a patient do if rapid-acting sublingual nitroglycerin gives no relief in 5 minutes?

Call EMS.

30
New cards

If some relief occurs after rapid-acting nitroglycerin, what repeat-dose instructions are listed?

Repeat every 5 minutes for a maximum of 3 doses.

31
New cards

How should sublingual nitroglycerin tablets be stored and when replaced?

Keep out of light and replace 6 months after opening.

32
New cards

When can rapid-acting nitrates be used prophylactically?

5–10 minutes before activity.

33
New cards

Where should nitroglycerin spray be applied?

Under or on top of the tongue.

34
New cards

Can nitroglycerin, isosorbide mononitrate, and isosorbide dinitrate be interchanged?

No; they cannot be interchanged.

35
New cards

What is the instruction for extended-release nitrate tablets?

Do not crush.

36
New cards

What oral administration instruction is listed for long-acting nitrates?

Take with food and/or 8 ounces of water.

37
New cards

How should nitrate ointment be applied?

Rotate sites; use the included paper and a hairless area.

38
New cards

What are the nitrate patch instructions?

Apply to clean, hairless skin; rotate sites and dispose of patches carefully.

39
New cards

What are major limitations of nitrate therapy?

Tolerance and adverse effects.

40
New cards

What is the example of a direct vasodilator used for HTN and CHF?

Hydralazine.

41
New cards

What handwritten caution is listed for hydralazine?

Arteriolar-only action; used with other medications (beta-blocker and diuretic); can cause reflex tachycardia and sodium/water retention.

42
New cards

What combination direct vasodilator is listed for CHF?

Hydralazine plus isosorbide dinitrate (BiDil).

43
New cards

What ARNI is listed for CHF?

Sacubitril/valsartan (Entresto).

44
New cards

What special-population caution is written for Entresto?

No pregnant patients.

45
New cards

What two mechanisms are identified in the Entresto annotation?

Angiotensin receptor antagonism and neprilysin inhibition; neprilysin breaks down BNP.

46
New cards

What is the mechanism of action of statins?

Competitively inhibit HMG-CoA reductase to block cholesterol synthesis in the liver.

47
New cards

How much can statins lower LDL?

25%–65%.

48
New cards

How do statins affect triglycerides and HDL?

Decrease triglycerides 10%–40%; increase HDL 5%–17%.

49
New cards

Which statins are exceptions to the slide's CYP3A4 metabolism statement?

Fluvastatin and rosuvastatin.

50
New cards

What does the slide note about Asian patients and rosuvastatin?

Reduced CYP2C9 activity is noted; a lower starting dose may be needed.

51
New cards

What are the contraindications listed for statins?

Liver disease, pregnancy, lactation.

52
New cards

What adverse effects are listed for statins?

Headache, rash, GI disturbances, myopathy/rhabdomyolysis, hepatotoxicity.

53
New cards

What labs should be monitored with statin therapy?

CK, LFTs, and lipid panel.

54
New cards

What patient-related factors increase the risk of statin-associated myopathy?

Age, small body frame, multisystem disease (especially renal disease and diabetes), low vitamin D/coenzyme Q, hypothyroidism.

55
New cards

What medication-related factors increase the risk of statin-associated myopathy?

High-dose/high-intensity statins, concurrent fibrates such as gemfibrozil, or CYP3A4 inhibitors.

56
New cards

What baseline information and dosing approach are recommended before starting statins?

Know renal and liver function; start low and go slow.

57
New cards

What food interaction and administration timing are emphasized for statins?

Avoid grapefruit juice; take short-acting statins at night; take without regard to food.

58
New cards

What are the LDL reductions defining high-, moderate-, and low-intensity statin therapy?

High ≥50%; moderate 30%–49%; low <30%.

59
New cards

Which statins and doses are listed as high intensity?

Atorvastatin 40–80 mg; rosuvastatin 20–40 mg.

60
New cards

Which statins and doses are listed as moderate intensity?

Atorvastatin 10–20 mg; rosuvastatin 5–10 mg; simvastatin 20–40 mg; pravastatin 40–80 mg; lovastatin 40–80 mg; fluvastatin XL 80 mg; fluvastatin 40 mg BID; pitavastatin 1–4 mg.

61
New cards

Which statins and doses are listed as low intensity?

Simvastatin 10 mg; pravastatin 10–20 mg; lovastatin 20 mg; fluvastatin 20–40 mg.

62
New cards

What class is ezetimibe (Zetia), and what is its indication?

Cholesterol absorption inhibitor; adjunct to diet and exercise to improve lipid levels.

63
New cards

What is the mechanism of action of ezetimibe?

Prevents small-intestinal cholesterol absorption, reducing liver cholesterol stores.

64
New cards

What are the pharmacokinetic and administration facts for ezetimibe?

Without regard to food; half-life 22 hours (bile); no renal dose reduction as monotherapy; liver dose reduction.

65
New cards

What cautions and adverse effects are listed for ezetimibe?

Caution with statin coadministration in liver disease; increased LFTs (especially with statin), diarrhea, muscle aches.

66
New cards

What special-population information is listed for ezetimibe?

Pregnancy C, lactation unknown, children >10 years.

67
New cards

What are ezetimibe's prescribing pearls, combination product, and LDL reduction?

Usually second-line add-on to a statin, take at same time as statin; with simvastatin = Vytorin; LDL reduction 15%–25%.

68
New cards

What class is evolocumab (Repatha), and what are its indications?

PCSK9 inhibitor; adjunct to diet/exercise for primary hyperlipidemia and familial hypercholesterolemia, plus major cardiovascular event risk reduction.

69
New cards

How does evolocumab lower LDL?

Inhibits PCSK9, which interferes with the pathway for LDL clearance, allowing more LDL to be cleared.

70
New cards

What are the administration, half-life, and dose-adjustment facts for evolocumab?

Subcutaneous injection; half-life 11–20 days; every 2 weeks or monthly; no renal or hepatic dose reductions.

71
New cards

What are evolocumab's cautions, adverse effects, and prescribing pearls?

Hypersensitivity including angioedema; minimal adverse effects listed; expensive with no generic; lowers LDL 50%–60%.

72
New cards

What special-population information is listed for evolocumab?

Pregnancy and lactation unknown; children >10 years.

73
New cards

What class is bempedoic acid (Nexletol), and what are its indications?

ACL (ATP-citrate lyase) inhibitor; adjunct to diet/exercise for primary hyperlipidemia, familial hypercholesterolemia, and major cardiovascular event risk reduction.

74
New cards

How does bempedoic acid work and how much does it lower LDL?

Blocks liver cholesterol synthesis upstream from statins; lowers LDL 15%–25%.

75
New cards

What are the administration and dose-adjustment facts for bempedoic acid?

Without regard to food; no renal dose reductions; no hepatic dose reductions in mild-to-moderate disease (not studied in severe disease).

76
New cards

What are the cautions and adverse effects listed for bempedoic acid?

Cautions: angioedema, hyperuricemia, tendon rupture especially >60 years, coadministration with simvastatin or pravastatin. AEs: URI, back pain, abdominal pain.

77
New cards

What special-population and prescribing pearls are listed for bempedoic acid?

Pregnancy risk vs. benefit; avoid in lactation; not indicated for children. Good for patients unable to tolerate statins; with ezetimibe = Nexlizet.

78
New cards

What are the indications for prescription omega-3 fatty acids?

Hypertriglyceridemia >500 mg/dL; cardiovascular risk reduction for Vascepa only.

79
New cards

How do Lovaza and Vascepa differ in lipid effects?

Lovaza reduces TG 20%–50% and may increase LDL; icosapent ethyl (Vascepa) reduces TG >30% and is more expensive.

80
New cards

What prescribing precautions are listed for prescription omega-3 fatty acids?

OTC products not recommended due to varied quality; review estrogens, beta-blockers, and thiazides that may worsen the problem; use caution with anticoagulants and antiplatelets; swallow capsules whole.

81
New cards

How do food instructions differ for Vascepa and Lovaza?

Vascepa always with food; Lovaza without regard to food.